May 13, 2020

Global Immunoassay Market Reach over US$ 26.1 bn by 2020-2027

According to the Acumen Research and Consulting, the global Immunoassay market is expected to reach at US$ 26.1 billion by 2026, along with the projected CAGR of 4.9% from 2020-2026.

The published report global Immunoassay market provides a holistic overview of the current market covering the current trends. The provided quantitative and qualitative data is based on the deeper analysis of the historical data and the current market situation that helps to provide an overview of the forecasted period.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1277

The global Immunoassay market report provides deeper insights on the factors driving the global market along with the factors that are responsible to hamper the growth. In addition, the report provides the opportunities in the global Immunoassay market that would help the competitors to increase the profit share.

The global Immunoassay market report provides the quantitative information of the target segment that is covered in the report along with the regional data comparison.

The report provides an overview value chain analysis, Porters Five analysis, and cost structure analysis gives an idea of the industrial outlook. The global Immunoassay market report covers the data of the major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the report also covers the country cross section providing deeper insights of the particular region.

The published global Immunoassay market report provides information about the major players operating in the target market. The company profile section provides important information about the major players, along with the financial overview, product segment revenue, the geographical presence of the company. It also provides information related to business development activities by the players such as merger & acquisition, partnerships and agreements.

The global Immunoassay market report also covers the products information that is offered by the particular players along with the specification. In addition, the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.

Market participants

Dickinson & Company; Becton, Thermo Fisher Scientific, Inc.; BioMΓ©rieux; Siemens Healthineers; Abbott laboratories; Roche Diagnostics; Sysmex Corporation; Danaher Corporation; Ortho Clinical Diagnostics; and Quidel Corporation.

Market segmentation

Immunoassay Market by Technology

  • Enzyme Immunoassay (EIA)
    • Fluorescence Immunoassays (FIA)
    • Chemiluminescence Immunoassays (CLIA)
  • Radioimmunoassay (RIA)
  • Rapid test
  • Others

Immunoassay Market by Product

  • Analyzers/instruments
    • Closed ended systems
    • Open ended systems
  • Reagents & kits
  • Software & services

Immunoassay Market by Application

  • Endocrinology
  • Therapeutic drug monitoring
  • Autoimmune diseases
  • Infectious disease testing
  • Cardiology
  • Others

Immunoassay Market by End-Use

  • Hospitals
  • Pharmaceutical and biotech companies
  • Clinical laboratories
  • Academic research centers
  • Blood banks
  • Others

Global Immunoassay Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Immunoassay
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Immunoassay Market By Technology
1.2.2.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Immunoassay Market Revenue Share By Technology in 2017
1.2.2.3. Enzyme Immunoassay (EIA)
1.2.2.3.1. Fluorescence Immunoassays (FIA)
1.2.2.3.2. Chemiluminescence Immunoassays (CLIA)
1.2.2.4. Radioimmunoassay (RIA)
1.2.2.5. Rapid test
1.2.2.6. Others
1.2.3. Immunoassay Market By Product
1.2.3.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Global Immunoassay Market Revenue Share By Product in 2017
1.2.3.3. Analyzers/instruments
1.2.3.3.1. Closed ended systems
1.2.3.3.2. Open ended systems
1.2.3.4. Reagents & kits
1.2.3.5. Software & services
1.2.3.6. Others
1.2.4. Immunoassay Market By Application
1.2.4.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Immunoassay Market Revenue Share By Application in 2017
1.2.4.3. Endocrinology
1.2.4.4. Therapeutic drug monitoring
1.2.4.5. Autoimmune diseases
1.2.4.6. Infectious disease testing
1.2.4.7. Cardiology
1.2.4.8. Others
1.2.5. Immunoassay Market By End-Use
1.2.5.1. Global Immunoassay Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.5.2. Global Immunoassay Market Revenue Share By End-Use in 2017
1.2.5.3. Hospitals
1.2.5.4. Pharmaceutical and biotech companies
1.2.5.5. Clinical laboratories
1.2.5.6. Academic research centers
1.2.5.7. Blood banks
1.2.5.8. Others
1.2.6. Immunoassay Market by Geography
1.2.6.1. Global Immunoassay Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Immunoassay Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Immunoassay Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Immunoassay Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Immunoassay Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Immunoassay Major Manufacturers in 2017
CHAPTER 4. Immunoassay Market By Technology
4.1. Global Immunoassay Revenue By Technology
4.2. Enzyme Immunoassay (EIA)
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.2.3. Fluorescence Immunoassays (FIA)
4.2.4. Chemiluminescence Immunoassays (CLIA)
4.3. Radioimmunoassay (RIA)
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Rapid test
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. Immunoassay Market By Product
5.1. Global Immunoassay Revenue By Product
5.2. Analyzers/instruments
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.2.3. Closed ended systems
5.2.4. Open ended systems
5.3. Reagents & kits
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Software & services
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. Immunoassay Market By Application
6.1. Global Immunoassay Revenue By Application
6.2. Endocrinology
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Therapeutic drug monitoring
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Autoimmune diseases
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. Infectious disease testing
6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.6. Cardiology
6.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.7. Others
6.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 7. Immunoassay Market By End-Use
7.1. Global Immunoassay Revenue By End-Use
7.2. Hospitals
7.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.3. Pharmaceutical and biotech companies
7.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.4. Clinical laboratories
7.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.5. Academic research centers
7.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.6. Blood banks
7.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.7. Others
7.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 8. North America Immunoassay Market By Country
8.1. North America Immunoassay Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. North America Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Immunoassay Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
CHAPTER 9. Europe Immunoassay Market By Country
9.1. Europe Immunoassay Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Europe Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
CHAPTER 10. Asia-Pacific Immunoassay Market By Country
10.1. Asia-Pacific Immunoassay Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Asia-Pacific Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.6.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.7.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.8.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
CHAPTER 11. Latin America Immunoassay Market By Country
11.1. Latin America Immunoassay Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Latin America Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
CHAPTER 12. Middle East Immunoassay Market By Country
12.1. Middle East Immunoassay Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Middle East Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
CHAPTER 13. Africa Immunoassay Market By Country
13.1. Africa Immunoassay Market Revenue and Growth Rate, 2015 – 2026 ($Million)
13.2. Africa Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
13.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
13.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
13.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
CHAPTER 14. COMPANY PROFILE
14.1. Dickinson & Company
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Becton
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. BioMΓ©rieux
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Siemens Healthineers
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Abbott laboratories
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Roche Diagnostics
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. Sysmex Corporation
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Danaher Corporation
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies
14.10. Ortho Clinical Diagnostics
14.10.1. Company Snapshot
14.10.2. Overview
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Key Developments
14.10.6. Strategies
14.11. Quidel Corporation
14.11.1. Company Snapshot
14.11.2. Overview
14.11.3. Financial Overview
14.11.4. Product Portfolio
14.11.5. Key Developments
14.11.6. Strategies
14.12. Others
14.12.1. Company Snapshot
14.12.2. Overview
14.12.3. Financial Overview
14.12.4. Product Portfolio
14.12.5. Key Developments
14.12.6. Strategies
CHAPTER 15. RESEARCH APPROACH
15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1277

Contact us:

Sheetal k

Email: [email protected]

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com